Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J3-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
filingDate |
1994-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c7f3aef9d94c82af94aca870afc70f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7be1365656ab17379bb3df15dfd7751e |
publicationDate |
1995-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H07149657-A |
titleOfInvention |
Finely ground colestipol hydrochloride and pharmaceutical composition for antihypercholesterolemia containing the same as active ingredient |
abstract |
(57) [Summary] [Objective] The conventional granule form of colestipol hydrochloride has a sandy texture, is not pharmaceutically elegant and improves it. [Composition] More than 95% of the particles are non-spherical crushed particles, and more than 75 (weight or volume) of the particles have a diameter of 65 Finely divided cholestipol hydrochloride having a particle size of less than 30 μm and a diameter of less than 30 (weight or volume)% of less than 30 μm, and a pharmaceutical composition for antihypercholesterolemia in a unit dosage form containing the same as an active ingredient. [Effect] The colestipol hydrochloride of the present invention is sufficiently convenient and effective for patients, and is pharmaceutically elegant. |
priorityDate |
1988-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |